Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Brain Metastases and Treatment, Glioma Diagnosis and Treatment, Advanced Radiotherapy Techniques, and Lung Cancer Research Studies.
Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patients with brain metastases
Abstract LB081: Carboxyamidotriazole orotate (CTO) with temozolomide (TMZ) for recurrent high-grade gliomas (rHGG) and in combination with TMZ/RT->TMZ in newly diagnosed glioblastoma (ndGBM): Long term follow-up of phase IB trial
Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
Frequency and outcomes of brain metastases in patients with <i>HER2</i>‐mutant lung cancers
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool
Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
The radiosurgery fractionation quandary: single fraction or hypofractionation?
The Prognostic Value of BRAF , C-KIT , and NRAS Mutations in Melanoma Patients With Brain Metastases
Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma
Estimating Survival in Patients With Lung Cancer and Brain Metastases
Corticosteroids compromise survival in glioblastoma
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
Ipilimumab and whole brain radiation therapy for melanoma brain metastases
Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma
The role of radiotherapy following gross-total resection of atypical meningiomas